![Stephen Cohen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Cohen
Net worth: 3 M $ as of 2024-05-30
Career history of Stephen Cohen
Former positions of Stephen Cohen
Companies | Position | Start | End |
---|---|---|---|
Oscient Pharmaceuticals Corp.
![]() Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Director of Finance/CFO | - | 2006-05-21 |
Statistics
International
United States | 2 |
Operational
Director of Finance/CFO | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Oscient Pharmaceuticals Corp.
![]() Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
- Stock Market
- Insiders
- Stephen Cohen
- Experience